We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

31 hedge funds and large institutions have $108M invested in Genocea Biosciences, Inc. in 2014 Q1 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
31
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$25.6M
2
DM
Deerfield Management
New York
+$10.1M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$5.65M
4
Jennison Associates
Jennison Associates
New York
+$3.06M
5
Axa
Axa
France
+$2.55M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
26
Nationwide Fund Advisors
Ohio
$22K +$18.4K +150 New
BA
27
BlackRock Advisors
Delaware
$21K +$17.6K +144 New
Bank of America
28
Bank of America
North Carolina
$16K +$13.8K +113 New
TRCT
29
Tower Research Capital (TRC)
New York
$12K +$10.3K +84 New
Barclays
30
Barclays
United Kingdom
$2K +$1.59K +13 New
Citigroup
31
Citigroup
New York
– +$368 +3 New
1
2

GNCA Hedge Fund Activity: Q1 2014 in Review

31 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q1 2014, worth a combined $108M.

Buyers outnumbered sellers: 31 funds opened new GNCA positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $25.6M.

  • 31 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $108M of Genocea Biosciences, Inc. stock for Q1 2014.
  • 31 funds opened new Genocea Biosciences, Inc. positions in Q1 2014 and 0 closed out, a net change of +31 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q1 2014 was Fidelity Investments, an estimated $25.6M added.

Based on aggregated 13F filings for Q1 2014.